Scancell
SEARCH
  • HOME
  • COMPANY
  • TECHNOLOGY
    • IMMUNOBODY
    • MODITOPE
    • AVIDIMAB
    • COVIDITY
    • SCIENTIFIC PAPERS & POSTERS
  • PRODUCTS
    • PRODUCT PIPELINE
    • SCIB1
    • SCIB2
    • Modi-1
    • Modi-2
  • INVESTORS
    • COMPANY PROFILE
    • ADVISORS
    • CORPORATE GOVERNANCE
    • DOCUMENTS & PRESENTATIONS
    • SHARE INFO
    • FINANCIAL INFO
    • 2020 CAPITAL RAISE
    • REGULATORY NEWS
    • REGULATORY NEWS ARCHIVE
  • NEWS
    • LATEST NEWS
    • INTERVIEWS
    • MEDIA COVERAGE
    • WEBCASTS
    • YEAR - 2020
    • YEAR - 2019
    • YEAR - 2018
    • YEAR - 2017
    • YEAR - 2016
    • YEAR - 2015
  • CONTACT US
SEARCH
  • NEWS
  • HOME
  • COMPANY
  • TECHNOLOGY
    • IMMUNOBODY
    • MODITOPE
    • AVIDIMAB
    • COVIDITY
    • SCIENTIFIC PAPERS & POSTERS
  • PRODUCTS
    • PRODUCT PIPELINE
    • SCIB1
    • SCIB2
    • Modi-1
    • Modi-2
  • INVESTORS
    • COMPANY PROFILE
    • ADVISORS
    • CORPORATE GOVERNANCE
    • DOCUMENTS & PRESENTATIONS
    • SHARE INFO
    • FINANCIAL INFO
    • 2020 CAPITAL RAISE
    • REGULATORY NEWS
    • REGULATORY NEWS ARCHIVE
  • NEWS
    • LATEST NEWS
    • INTERVIEWS
    • MEDIA COVERAGE
    • WEBCASTS
    • YEAR - 2020
    • YEAR - 2019
    • YEAR - 2018
    • YEAR - 2017
    • YEAR - 2016
    • YEAR - 2015
  • CONTACT US

News

Vulpes Life Sciences Fund's Martin Diggle discusses Scancell investment

[View interview]

Friday 21 June 2019 13:00 Categories: Interviews Media Coverage Year - 2019

Scancell Board Appointment

To download click here.

Tuesday 18 June 2019 13:00 Categories: News Regulatory News Year - 2019

Scancell Announces Share Subscription and Issue of Equity to Vulpes Life Sciences Fund

To download click here.

Thursday 13 June 2019 13:00 Categories: News Regulatory News Year - 2019

Scancell raises £3.9mln to advance immunotherapy product pipeline

“At Vulpes we are always searching for overlooked companies that have the ability to make significant advances in medical science, with a view to supporting their development over the long term. We believe Scancell fulfil these criteria perfectly.”

[View article]

Thursday 13 June 2019 13:00 Categories: Media Coverage News Year - 2019

Scancell welcomes strategic new investor Vulpes Life Sciences Fund

[View interview]

Thursday 13 June 2019 13:00 Categories: Interviews Media Coverage Year - 2019

Scancell exploring new frontiers in cancer research

Here we take a closer look at Scancell, which is at the vanguard of immuno-oncology

[View article]

Monday 20 May 2019 14:51 Categories: Media Coverage Modi-1 SCIB1 SCIB2 Year - 2019

Scancell and Cancer Research UK provide an update on the development of SCIB2, a novel cancer immunotherapy

To download click here.

Monday 20 May 2019 13:00 Categories: News Regulatory News SCIB2 Year - 2019

Scancell surges after announcing milestone in development of its solid tumours treatment

Scancell has a clinical development partnership with Cancer Research UK, the world's leading cancer charity dedicated to saving lives through research

[View article]

Monday 20 May 2019 11:23 Categories: Immunobody Media Coverage SCIB2 Year - 2019

Scancell Establishes Clinical Advisory Board and Provides Update on Modi-1 Progress

To download click here

Friday 10 May 2019 13:00 Categories: Modi-1 Moditope News Regulatory News Year - 2019

Scancell adds six ‘world-leading’ cancer specialists to advisory board ahead of Modi-1 trial

“The initial focus of the board will be to inform the clinical strategy for the planned Modi-1 clinical trial and to ensure the best possible outcome in several solid tumour indications”

[View article]

Friday 10 May 2019 10:45 Categories: Media Coverage Modi-1 Moditope Year - 2019
  • Page 6 of 33
  • 
  • 
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 20
  • 30
  • 
  • 

Categories

  • AvidiMab (9)
  • Covid-19 (7)
  • Immunobody (111)
  • Interviews (10)
  • Media Coverage (40)
  • Modi-1 (37)
  • Modi-2 (4)
  • Moditope (75)
  • News (282)
  • Presentations (5)
  • Regulatory News (253)
  • SCIB1 (134)
  • SCIB2 (21)
  • Webcasts (1)
  • Year - 2014 and older (142)
  • Year - 2015 (15)
  • Year - 2016 (31)
  • Year - 2017 (21)
  • Year - 2018 (42)
  • Year - 2019 (47)
  • Year - 2020 (30)
  • Company
  • Overview
  • Board of Directors
  • Management
  • Clinical Advisory Board
  • Partnerships
  • Technology
  • Immunobody
  • Moditope
  • AvidiMab
  • Scientific Papers & Posters
  • Products
  • Product Pipeline
  • SCIB1
  • SCIB2
  • Modi-1
  • Modi-2
  • Investors
  • Company Profile
  • Advisors
  • Corporate Governance
  • Documents & Presentations
  • Share Information
  • Financial Information
  • Regulatory News
  • News
  • Latest News
  • Contact Us

News updates

Sign up for news updates to stay up to date with Scancell

Privacy & legal notes ©Copyright Scancell 2021